A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
Recruiting · NCT06594991 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma | Advanced Melanoma | Recruiting | Phase 2 | 2026-10-07 | NCT06594991 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
| Regeneron Pharmaceuticals | 238 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles | United States | 392 |
| Hackensack Meridian Health (Data Collection Only) | Hackensack | United States | 6 |
| Hartford Healthcare Alliance (Data Collection Only) | Hartford | United States | 6 |
| MD Anderson Cancer Center (Data Collection Only) | Houston | United States | 9 |
| Memorial Sloan Kettering Basking Ridge (All Protocol Activities) | Basking Ridge | United States | 56 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | United States | 184 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |
| Memorial Sloan Kettering Monmouth (All Protocol Activities) | Middletown | United States | 92 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | United States | 120 |
| Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) | Commack | United States | 55 |
| Memorial Sloan Kettering Westchester (All Protocol Activities) | Harrison | United States | 86 |
| Stanford University (Data Collection Only) | Stanford | United States | 3 |